Fluid biomarkers for synaptic dysfunction and loss

E Camporesi, J Nilsson, A Brinkmalm… - Biomarker …, 2020 - journals.sagepub.com
Synapses are the site for brain communication where information is transmitted between
neurons and stored for memory formation. Synaptic degeneration is a global and early …

Vitamin D and neurological diseases: an endocrine view

C Di Somma, E Scarano, L Barrea… - International journal of …, 2017 - mdpi.com
Vitamin D system comprises hormone precursors, active metabolites, carriers, enzymes, and
receptors involved in genomic and non-genomic effects. In addition to classical bone-related …

MS-GF+ makes progress towards a universal database search tool for proteomics

S Kim, PA Pevzner - Nature communications, 2014 - nature.com
Mass spectrometry (MS) instruments and experimental protocols are rapidly advancing, but
the software tools to analyse tandem mass spectra are lagging behind. We present a …

Behind the scenes of vitamin D binding protein: more than vitamin D binding

JR Delanghe, R Speeckaert, MM Speeckaert - Best practice & research …, 2015 - Elsevier
Although being discovered in 1959, the number of published papers in recent years reveals
that vitamin D binding protein (DBP), a member of the albuminoid superfamily, is a hot …

Synaptic elimination in neurological disorders

PL Cardozo, IBQ de Lima, EMA Maciel… - Current …, 2019 - benthamdirect.com
Synapses are well known as the main structures responsible for transmitting information
through the release and recognition of neurotransmitters by pre-and post-synaptic neurons …

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

G Hinsinger, N Galéotti, N Nabholz… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background: Despite sensitivity of MRI to diagnose multiple sclerosis (MS), prognostic
biomarkers are still needed for optimized treatment. Objective: The objective of this paper is …

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration

N Gómez de San José, F Massa… - Journal of Neural …, 2022 - Springer
The diagnosis of neurodegenerative disorders is often challenging due to the lack of
diagnostic tools, comorbidities and shared pathological manifestations. Synaptic dysfunction …

Proteomics in multiple sclerosis: the perspective of the clinician

D Sandi, Z Kokas, T Biernacki, K Bencsik… - International Journal of …, 2022 - mdpi.com
Multiple sclerosis (MS) is the inflammatory demyelinating and neurodegenerative disease of
the central nervous system (CNS) that affects approximately 2.8 million people worldwide. In …

In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)

A Guldbrandsen, H Vethe, Y Farag, E Oveland… - Molecular & cellular …, 2014 - ASBMB
In this study, the human cerebrospinal fluid (CSF) proteome was mapped using three
different strategies prior to Orbitrap LC-MS/MS analysis: SDS-PAGE and mixed mode …

Exploring the human tear fluid: D iscovery of new biomarkers in multiple sclerosis

C Salvisberg, N Tajouri, A Hainard… - PROTEOMICS …, 2014 - Wiley Online Library
Purpose Multiple sclerosis is the first cause of progressive neurological disability among
young adults living in W estern countries. Its diagnosis is mostly based on clinical …